Otofarma SpA (MIL:OTO) Stock Based Compensation: €0.00 Mil (TTM As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Stock Based Compensation?

Otofarma SpA MIL:OTO 16 Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Stock Based Compensation for the six months ended in Dec. 2024 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Otofarma SpA Stock Based Compensation Related Terms

Otofarma SpA Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Stock Based Compensation Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Stock Based Compensation
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Stock Based Compensation 0.00 0.00
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Otofarma SpA (MIL:OTO) has a Stock Based Compensation of €0.00 Mil as of Dec. 2024. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Otofarma SpA and its competitors.
Is Otofarma SpA's Stock Based Compensation too high?
Otofarma SpA's current Stock Based Compensation is €0.00 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Stock Based Compensation compare to ABT and SYK?
Otofarma SpA's Stock Based Compensation of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Otofarma SpA and its competitors. Otofarma SpA's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Stock Based Compensation of €0.00 Mil. The current Stock Based Compensation is €0.00 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Stock Based Compensation is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price